We need your voice to help inform next steps in Massachusetts and the Northeast Region.
17P: Clinical, Public Health & Policy Approaches to Increased AccessWednesday, February 15th 20178:30 AM – 12:30 PMFederal Reserve Plaza, New England Room600 Atlantic Ave. Boston, MA 02210
Meeting Objectives: 1. Assemble a team of leaders with the authority, expertise, credibility, and motivation necessary to drive a successful initiative to increase access to 17 alpha-hydroxyprogesterone caproate and reduce preterm birth2. Gain an understanding of clinical progress to date to inform future initiatives designed to increase access to 17 alpha-hydroxyprogesterone caproate3. Review current Massachusetts insurance policies on progesterone 4. Develop next steps for the MA project plan to increase access to 17 alpha-hydroxyprogesterone caproate
8:00 – 8:30 Breakfast & Registration
8:30 – 9:20 Opening Plenary I Introductory Remarks National Perspective Massachusetts’ Progress to Date
9:20 – 9:50 Keynote Presentation
10:00-11:20 Plenary II 17P at the Institutional Level – One MA Hospital Medicaid & Payer Policy in MA Patient/Consumer Perspective
11:30-12:30 Q&A Panel MA – Actionable Items and Next Steps